Last update: Aug. 12, 2014

Isoprenaline

Very Low Risk for breastfeeding


Safe. Compatible.
Minimal risk for breastfeeding and infant.

Inhaled bronchodilator drugs are preferred because of a lower secretion into breast milk.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Isoprenaline is also known as


Tradenames

Main tradenames from several countries containing Isoprenaline in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. < 20 %
Molecular weight 211 daltons
Tmax 0,2 hours
T1/2 2 hours

References

  1. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Full text (link to original source) Full text (in our servers)
  2. Reyes G, Schwartz PH, Newth CJ, Eldadah MK. The pharmacokinetics of isoproterenol in critically ill pediatric patients. J Clin Pharmacol. 1993 Abstract
  3. Morgan DJ. Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet. 1990 Abstract

Total visits

2,730

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM